("tmc-125"[MeSH Terms] OR tmc-125[Text Word])

Knoll BM, Vento S, Temesgen Z.

Drugs Today (Barc). 2008 Jan;44(1):23-33. Review.

PMID: 18301801 [PubMed - indexed for MEDLINE]

Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors.

Poveda E, Garrido C, de Mendoza C, Corral A, Cobo J, González-Lahoz J, Soriano V.

J Antimicrob Chemother. 2007 Dec;60(6):1409-10. Epub 2007 Oct 3. No abstract available.

PMID: 17913723 [PubMed - indexed for MEDLINE]

Antiretroviral treatment of HIV infection: Swedish recommendations 2007.

Josephson F, Albert J, Flamholc L, Gisslén M, Karlström O, Lindgren SR, Navér L, Sandström E, Svedhem-Johansson V, Svennerholm B, Sönnerborg A.

Scand J Infect Dis. 2007;39(6-7):486-507. Review.

PMID: 17577810 [PubMed - indexed for MEDLINE]

Expanded drug access: etravirine (formerly TMC-125).

Colquitt AR, Pham PA.

Hopkins HIV Rep. 2007 Jan;19(1):8-10. No abstract available.

PMID: 17569170 [PubMed - indexed for MEDLINE]

Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future.

De Clercq E.

Chem Biodivers. 2004 Jan;1(1):44-64. Review.

PMID: 17191775 [PubMed - indexed for MEDLINE]

Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs).

Hang JQ, Li Y, Yang Y, Cammack N, Mirzadegan T, Klumpp K.

Biochem Biophys Res Commun. 2007 Jan 12;352(2):341-50. Epub 2006 Nov 14.

PMID: 17113568 [PubMed - indexed for MEDLINE]

Etravirine: R165335, TMC 125, TMC-125, TMC125.

[No authors listed]

Drugs R D. 2006;7(6):367-73. Review.

PMID: 17073519 [PubMed - indexed for MEDLINE]

Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors.

Boone LR.

Curr Opin Investig Drugs. 2006 Feb;7(2):128-35. Review.

PMID: 16499282 [PubMed - indexed for MEDLINE]

New targets and new drugs in the treatment of HIV.

López-Aldeguer J, Aguirrebengoa K, Arribas JR, Esté JA, Kindelán JM.

Enferm Infecc Microbiol Clin. 2005 Jul;23(Supl.2):33-40.

PMID: 16373002 [PubMed - as supplied by publisher]

10:

[New targets and new drugs in the treatment of HIV.]

López-Aldeguer J, Aguirrebengoa K, Arribas JR, Esté JA, Kindelán JM.

Enferm Infecc Microbiol Clin. 2005 Jul;23 Suppl 2:25-32. Spanish.

PMID: 16373001 [PubMed - in process]

11:

Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells.

Njai HF, Lewi PJ, Janssen CG, Garcia S, Fransen K, Kestens L, Vanham G, Janssen PA.

Antivir Ther. 2005;10(2):255-62.

PMID: 15865220 [PubMed - indexed for MEDLINE]

12:

TMC 125 possibly effective against NNRTI-resistant HIV.

[No authors listed]

IAPAC Mon. 2004 Jan;10(1):9. No abstract available.

PMID: 15108674 [PubMed - indexed for MEDLINE]

13:

TMC-125 Tibotec.

Haslinger BA, Arendt G.

Curr Opin Investig Drugs. 2004 Feb;5(2):208-13. Review.

PMID: 15043396 [PubMed - indexed for MEDLINE]

14:

An open-label assessment of TMC 125--a new, next-generation NNRTI, for 7 days in HIV-1 infected individuals with NNRTI resistance.

Gazzard BG, Pozniak AL, Rosenbaum W, Yeni GP, Staszewski S, Arasteh K, De Dier K, Peeters M, Woodfall B, Stebbing J, vant' Klooster GA.

AIDS. 2003 Dec 5;17(18):F49-54.

PMID: 14685068 [PubMed - indexed for MEDLINE]

15:

New antiretroviral drugs.

Gulick RM.

Clin Microbiol Infect. 2003 Mar;9(3):186-93. Review.

PMID: 12667250 [PubMed - indexed for MEDLINE]

16:

Highlights in the development of new antiviral agents.

De Clercq E.

Mini Rev Med Chem. 2002 Apr;2(2):163-75. Review.

PMID: 12370077 [PubMed - indexed for MEDLINE]

17:

New anti-HIV agents and targets.

De Clercq E.

Med Res Rev. 2002 Nov;22(6):531-65. Review.

PMID: 12369088 [PubMed - indexed for MEDLINE]

18:

New developments in anti-HIV chemotherapy.

De Clercq E.

Biochim Biophys Acta. 2002 Jul 18;1587(2-3):258-75. Review.

PMID: 12084468 [PubMed - indexed for MEDLINE]

19:

[Improving resistance profile, simplifying administration mode. New antiretroviral drugs]

Arastéh K, Müller M.

MMW Fortschr Med. 2002 Apr 9;144 Suppl 1:66-70. German.

PMID: 12043080 [PubMed - indexed for MEDLINE]

Recent Activity